Jim Simons Allogene Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 642,009 shares of ALLO stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

642,009

Previous 1,747,955 63.27%

Holding current value

$1.42 Million

Previous $4.07 Million 55.87%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.08 - $3.5 $2.3 Million - $3.87 Million	-1,105,946 Reduced 63.27%	642,009 $1.8 Million
Q2 2024 Aug 09, 2024	BUY	$2.23 - $4.38 $3.01 Million - $5.92 Million	1,351,055 Added 340.4%	1,747,955 $4.07 Million
Q1 2024 May 13, 2024	SELL	$2.92 - $5.63 $180,304 - $347,641	-61,748 Reduced 13.46%	396,900 $1.77 Million
Q4 2023 Feb 13, 2024	BUY	$2.28 - $3.5 $976,674 - $1.5 Million	428,366 Added 1414.59%	458,648 $1.47 Million
Q3 2023 Nov 14, 2023	SELL	$3.17 - $5.96 $702,529 - $1.32 Million	-221,618 Reduced 87.98%	30,282 $96,000
Q2 2023 Aug 11, 2023	SELL	$4.53 - $6.74 $800,904 - $1.19 Million	-176,800 Reduced 41.24%	251,900 $1.25 Million
Q1 2023 May 12, 2023	SELL	$4.92 - $8.21 $56,088 - $93,594	-11,400 Reduced 2.59%	428,700 $2.12 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $11.11 $2.47 Million - $4.89 Million	440,100 New	440,100 $2.77 Million
Q2 2022 Aug 12, 2022	SELL	$6.78 - $12.28 $6.61 Million - $12 Million	-974,700 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.65 - $15.29 $7.46 Million - $14.9 Million	974,700 New	974,700 $8.88 Million
Q3 2021 Nov 12, 2021	SELL	$21.01 - $27.64 $14.8 Million - $19.5 Million	-704,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$23.49 - $35.8 $16.5 Million - $25.2 Million	704,400 New	704,400 $18.4 Million
Q4 2020 Feb 10, 2021	SELL	$25.24 - $43.45 $2.12 Million - $3.65 Million	-83,900 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$32.38 - $44.96 $1.9 Million - $2.64 Million	58,700 Added 232.94%	83,900 $3.16 Million
Q2 2020 Aug 13, 2020	BUY	$18.39 - $54.04 $463,428 - $1.36 Million	25,200 New	25,200 $1.08 Million

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $318M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account